--- title: "Antengene Corporation (6996) stock and investor profile" url: "https://aibio.space/companies/antengene/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Antengene Corporation Limited (HKEX: 6996), China. The directory classifies it as Pharmaceuticals: Major." --- 6996 Antengene Corporation Limited HKEX · China # Antengene Corporation (6996) news Antengene Corporation Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6996, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Antengene Corporation news We have not published a story on Antengene Corporation yet. When there is news, it will appear here. ## Antengene Corporation at a glance - **Ticker**: 6996 - **Listing**: HKEX - **Country**: China ### Related companies - [CASI Pharmaceuticals](https://aibio.space/companies/casi-pharmaceuticals/) OTC: CASIF - [Xiangxue Pharmaceutical Co.](https://aibio.space/companies/xiangxue-pharmaceutical/) SZSE: 300147 - [Hainan Huluwa Pharmaceutical Group Co.](https://aibio.space/companies/hainan-huluwa-pharmaceutical/) SSE: 605199 - [Hangzhou Bio-Sincerity Pharma-Tech Co.](https://aibio.space/companies/hangzhou-bio-sincerity-pharma-tech/) SZSE: 301096 - [Bide Pharmatech Co.](https://aibio.space/companies/bide-pharmatech/) SSE: 688073 - [Wanbangde Pharmaceutical Holding Group Co.](https://aibio.space/companies/wanbangde-pharmaceutical/) SZSE: 002082 - [InnoCare Pharma](https://aibio.space/companies/innocare-pharma/) SSE: 688428 - [Tuoxin Pharmaceutical Group Co.](https://aibio.space/companies/tuoxin-pharmaceutical/) SZSE: 301089 ### Also on HKEX - [HJ Science Co.](https://aibio.space/companies/hj-science/) 6132 - [Duality Biotherapeutics](https://aibio.space/companies/duality-biotherapeutics/) 9606 - [CPBIO Holding Company](https://aibio.space/companies/cpbio/) 3839 - [IMPACT Therapeutics](https://aibio.space/companies/impact-therapeutics/) 7630 - [Shanghai Henlius Biotech](https://aibio.space/companies/shanghai-henlius-biotech/) 2696 - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) 9966 ## Questions about Antengene Corporation What is the ticker symbol of Antengene Corporation? Antengene Corporation Limited trades under the ticker 6996 on HKEX. Where is Antengene Corporation listed? Antengene Corporation Limited is listed on HKEX. Which country or territory is Antengene Corporation listed under? Our directory records Antengene Corporation Limited under China. What does Antengene Corporation do? Our directory classifies Antengene Corporation Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Antengene Corporation? The ISIN recorded for Antengene Corporation Limited is KYG039571008. Does aibio.space cover Antengene Corporation? aibio.space lists Antengene Corporation Limited among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Antengene Corporation? Companies in our directory listed in the same country and business area as Antengene Corporation: CASI Pharmaceuticals, Xiangxue Pharmaceutical Co., Hainan Huluwa Pharmaceutical Group Co., Hangzhou Bio-Sincerity Pharma-Tech Co., Bide Pharmatech Co., Wanbangde Pharmaceutical Holding Group Co.. ## Investor discussion: Antengene Corporation Members talk about Antengene Corporation (6996). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Antengene Corporation, newest first. Each line links the filing it comes from. 1. 2026-04-29 Financings Share or debt issue: (1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF THE AUDITOR; (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901812.pdf) 2. 2025-04-27 Financings Share or debt issue: (1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; AND (3) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0427/2025042700051.pdf) ## Press releases Headlines of Antengene Corporation's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-10 HKEXnews [GRANT OF RSUs UNDER THE 2022 RSU SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0910/2026091001483.pdf) 2. 2026-08-24 HKEXnews [VOLUNTARY ANNOUNCEMENT HREC APPROVAL IN AUSTRALIA FOR PHASE I ATTRACT STUDY OF ATG-201 IN B CELL-RELATED AUTOIMMUNE DISEASES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500047.pdf) 3. 2026-08-21 HKEXnews [ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100945.pdf) 4. 2026-07-31 HKEXnews [(1) RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF FINANCIAL OFFICER (2) APPOINTMENT OF EXECUTIVE DIRECTOR (3) APPOINTMENT OF CHIEF BUSINESS OFFICER (4) CHANGE OF AUTHORIZED REPRESENTATIVE AND PROCESS AGENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073100634.pdf) 5. 2026-07-27 HKEXnews [POSITIVE PROFIT ALERT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0728/2026072800023.pdf) 6. 2026-07-13 HKEXnews [VOLUNTARY ANNOUNCEMENT RECEIPT OF USD60 MILLION UPFRONT PAYMENT FROM UCB FOR ATG-201](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0713/2026071300127.pdf) 7. 2026-06-24 HKEXnews [VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0625/2026062500079.pdf) 8. 2026-06-22 HKEXnews [VOLUNTARY ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT WITH MPM BIOIMPACT ESTABLISHED K2 THERAPEUTICS FOR ATG-106 AND OPTION FOR UNDISCLOSED BISPECIFIC TCE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0622/2026062200189.pdf) 9. 2026-06-10 HKEXnews [CHANGE OF JOINT COMPANY SECRETARIES AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001286.pdf) 10. 2026-06-10 HKEXnews [NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001250.pdf) 11. 2026-06-10 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061001221.pdf) 12. 2026-06-09 HKEXnews [VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR ATG-201 (CD19 x CD3 TCE) IN AUTOIMMUNE DISEASE IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0610/2026061000009.pdf) 13. 2026-05-27 HKEXnews [VOLUNTARY ANNOUNCEMENT CHINA IND APPROVAL FOR PIVOTAL PHASE III CLINCH-3 STUDY OF ATG-022 IN CLDN18.2+ ADVANCED GASTRIC/GEJ CANCER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052800013.pdf) 14. 2026-05-20 HKEXnews [VOLUNTARY ANNOUNCEMENT APPOINTMENT OF CHIEF SCIENTIFIC OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0520/2026052000076.pdf) 15. 2026-04-29 HKEXnews [NOTICE OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901836.pdf) 16. 2026-04-29 HKEXnews [(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF THE AUDITOR; (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (5) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901812.pdf) 17. 2026-04-29 HKEXnews [PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042901780.pdf) 18. 2026-04-07 HKEXnews [GRANT OF SHARE OPTIONS AND RSUS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0407/2026040700245.pdf) 19. 2026-03-25 HKEXnews [VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY FOUNDER, CEO, CHAIRMAN AND OTHER MANAGEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032500129.pdf) 20. 2026-03-20 HKEXnews [ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032000496.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6996 on TradingView](https://www.tradingview.com/symbols/HKEX-6996/). ## Listing details Antengene Corporation Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6996, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Antengene Corporation Limited - **Ticker**: 6996 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG039571008 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6996/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/antengene/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Antengene Corporation (6996) stock and investor profile", 2026-10-31, https://aibio.space/companies/antengene/